Comments and reply on The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries

Authors: Soto, Javier¹; Holmstrom, Stefan²; Buchholz, Patricia³; Walt, John⁴; Wickstrøm, Jannie⁵; Aagren, Mark⁵

Source: Current Medical Research and Opinion, Volume 22, Number 10, October 2006 , pp. 1899-1902(4)

Publisher: Informa Healthcare

Document Type: Letter section

DOI: http://dx.doi.org/10.1185/030079906X132569

Affiliations: 1: Health Outcomes Research, Medical Unit-Pfizer Spain, Avda de Europa 20-B, Parque Empresarial de la Moraleja, 28108 Alcobendas, Madrid, Spain 2: Biot, France 3: Allergan R&D Europe, Ettlingen, Germany 4: Allergan Global Health Outcomes, Irvine, CA, USA 5: MUUSMANN Research & Consulting, Copenhagen, Denmark

Publication date: 2006-10-01

• Information for Authors
• Subscribe to this Title
• Terms & Conditions
• General Information
• Journal Information
• ingentaconnect is not responsible for the content or availability of external websites

• In this: publication
• By this: publisher
• In this Subject: Medicine (General)
• By this author: Soto, Javier ;  Holmstrom, Stefan ;  Buchholz, Patricia ;  Walt, John ;  Wickstrøm, Jannie ;  Aagren, Mark

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers